Stryker Corp (SYK)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$350.00

Buy

$389.95

arrow-up$0.84 (+0.22%)

Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.
Prices updated at 30 May 2025, 21:40 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kevin A. Lobo
CEO
Mr. Kevin A. Lobo
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
53,000
Head office
1941 Stryker Way
Portage
United States
49002
mobile
+1 269 385-2600
letter
jason.beach@stryker.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Preston W. Wells
Vice President and Chief Financial Officer
-----
Ms. Ronda E. Stryker
Independent Director
0.13m--0.34m-
Ms. Sherilyn S. McCoy
Lead Independent Director
0.17m--0.38m-
Ms. Mary K. Brainerd
Independent Director
0.14m--0.36m-
Mr. Andrew K. Silvernail
Independent Director
0.15m--0.36m-
Mr. Kevin A. Lobo
Chairman of the Board, Chief Executive Officer and President
1.44m--21.98m-
Dr. Giovanni Caforio, M.D.
Independent Director
0.13m--0.34m-
Mr. William E. Berry, Jr
Vice President, Corporate Controller and Chief Accounting Officer
-----
Mr. Rajeev Suri
Independent Director
0.13m--0.34m-
Ms. Lisa M. Skeete Tatum
Independent Director
0.13m--0.34m-
Ms. Yin C. Becker
Vice President and Chief Corporate Affairs Officer
-----
Ms. M. Kathryn Fink
Vice President and Chief Human Resources Officer
-----
Mr. Viju S. Menon
Group President, Global Quality and Operations
0.65m--4.59m-
Mr. Spencer S. Stiles
Group President, Orthopaedics and Spine
0.75m--6.76m-
Mr. Robert S Fletcher
Vice President and Chief Legal Officer
-----
Ms. Rachel M. Ruggeri
Independent Director
0.08m--0.30m-
Mr. J. Andrew Pierce
Group President, MedSurg and Neurotechnology
0.75m--6.76m-
Mr. Emmanuel P. Maceda
Independent Director
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc33,059,9640.22253611361.10443130 Apr 20258.65
BlackRock Inc27,182,8530.212533727731.39042130 Apr 20257.11
Greenleaf Trust17,116,80258.1087-628360-3.54102130 Apr 20254.48
State Street Corp14,806,5280.22763274100.18546430 Apr 20253.87
JPMorgan Chase & Co12,617,2770.34296180807716.72720530 Apr 20253.30

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Mr. Glenn S. Boehnlein122.5136,7535,331--
31 Dec 2024-Mr. Glenn S. Boehnlein--9,015--
31 Dec 2024-Mr. Glenn S. Boehnlein362.2673,5395,128--
27 Dec 2024-Mr. Glenn S. Boehnlein369.42495,7625,031--
27 Dec 2024-Mr. Glenn S. Boehnlein--9,315--
27 Dec 2024-Mr. Glenn S. Boehnlein122.51245,0206,373--
23 Dec 2024-Mr. J. Andrew Pierce--607--
23 Dec 2024-Mr. J. Andrew Pierce--607--
23 Dec 2024-Mr. J. Andrew Pierce--55,413--
17 Dec 2024-Mr. William E. Berry, Jr372.7011,1815,040--
18 Nov 2024-Mr. Glenn S. Boehnlein390.081,162,0484,373--
18 Nov 2024-Mr. Glenn S. Boehnlein--11,315--
18 Nov 2024-Mr. Glenn S. Boehnlein122.51551,2957,352--
15 Nov 2024-Mr. Spencer Stiles391.16201,05650,611--
14 Nov 2024-Mr. Spencer Stiles--51,125--
07 Nov 2024-Mr. Kevin A. Lobo369.755,866,454100,027--
07 Nov 2024-Mr. Kevin A. Lobo-----
07 Nov 2024-Mr. Kevin A. Lobo368.588,542,947115,893--
07 Nov 2024-Mr. Kevin A. Lobo367.956,722,079139,071--
07 Nov 2024-Mr. Kevin A. Lobo369.0236,745,905157,340--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.